Skip to content

Asset turnover at other companies

Revolution Medicines, Inc. logo
Revolution Medicines, Inc.RVMD
Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
0.2×0.0×
Tango Therapeutics logo
Tango TherapeuticsTNGX
0.2×0.0×
Spyre Therapeutics, Inc. logo
Spyre Therapeutics, Inc.SYRE
LQD
Liquidia CorporationLQDA
0.9×+0.8×
Revvity logo
RevvityRVTY
0.2×0.0×

Other financials

Income statement

See full
Revenue$3.0M-60.9%
Operating income-$78.6M+7.4%
Net income-$73.3M+4.9%
EPS (diluted)-$0.41+10.9%

Balance sheet

See full
Cash & equivalents$204.6M+119%
Total debt$31.6M-33.1%
Total equity$642.2M-10.9%
Total assets$699.6M-12.5%

Cash flow

See full
Operating cash flow-$51.1M+30.2%
CapEx$1.0K
Free cash flow-$44.9M+22.5%

Valuation

See full
Market cap$3.8B+300%

Profitability

See full
Operating margin-2,776.6%-820pp
Net margin-2,554.1%-745pp
FCF margin-1,536%-429pp

Returns & leverage

See full
Return on equity-40%-4.3pp
Debt / equity0.0×
Current ratio22.1×+2.2×

Where this comes from

Calculated from Relay Therapeutics, Inc.’s reported figures.

Based on trailing twelve months.

The official record: Relay Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Relay Therapeutics, Inc.'s asset turnover.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Relay Therapeutics, Inc.'s asset turnover?
Relay Therapeutics, Inc. (RLAY) reported asset turnover of 0× in Q1 2026.
How has Relay Therapeutics, Inc.'s asset turnover changed year-over-year?
Relay Therapeutics, Inc.'s asset turnover increased by 51.1% year-over-year, from 0× to 0×.
What is the long-term trend for Relay Therapeutics, Inc.'s asset turnover?
Over 5 years (2020 to 2025), Relay Therapeutics, Inc.'s asset turnover has grown at a -31.7% compound annual growth rate (CAGR), from 0.1× to 0×.
What does asset turnover mean?
Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.